Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

EFTR eFFECTOR Therapeutics

0.562
-0.010-1.75%
Close 10/03 16:00 ET
0.5620.0000.00%
Post Mkt Price 10/03 16:00 ET
High
0.590
Open
0.590
Turnover
29.05K
Low
0.545
Pre Close
0.572
Volume
52.14K
Market Cap
23.31M
P/E(TTM)
1.44
52wk High
15.870
Shares
41.45M
P/E(Static)
1.44
52wk Low
0.470
Float Cap
8.62M
Bid/Ask %
-85.71%
Historical High
40.420
Shs Float
15.33M
Volume Ratio
0.52
Historical Low
0.470
Dividend TTM
--
Div Yield TTM
--
P/B
1.19
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.34%
Amplitude
7.83%
Avg Price
0.557
Lot Size
1
Float Cap
8.62M
Bid/Ask %
-85.71%
Historical High
40.420
Shs Float
15.33M
Volume Ratio
0.52
Historical Low
0.470
Dividend TTM
--
P/B
1.19
Dividend LFY
--
Turnover Ratio
0.34%
Amplitude
7.83%
Avg Price
0.557
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.
CEO: Dr. Stephen T. Worland,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...